An Efficacy and Safety Study of Theraflu Day Powder as Oral Solution for Cold and Flu
Status:
Withdrawn
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the short term efficacy of the Theraflu Aktiv powder
for oral solution in the Russian population as compared to an untreated group to support the
indication of "Short term relief of the symptoms of colds, chills and influenza, including
mild to moderate pain, fever and nasal congestion".